Misuse of Drugs (Designation) Order 2001

JurisdictionUK Non-devolved
CitationSI 2001/3997
Year2001

2001 No. 3997

DANGEROUS DRUGS

The Misuse of Drugs (Designation) Order 2001

Made 13th December 2001

Laid before Parliament 14th December 2001

Coming into force 1st February 2002

The Secretary of State, in exercise of the powers conferred on him by section 7(4) and (5) of the Misuse of Drugs Act 19711, on the recommendation of the Advisory Council on the Misuse of Drugs, hereby makes the following Order:

S-1 This Order may be cited as the Misuse of Drugs (Designation)...

1. This Order may be cited as the Misuse of Drugs (Designation) Order 2001 and shall come into force on 1st February 2002.

S-2 The controlled drugs specified in Part I of the Schedule to...

2.—(1) The controlled drugs specified in Part I of the Schedule to this Order are designated as drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies.

(2) Part II of the Schedule to this Order shall have effect for the purpose of specifying those controlled drugs which are excepted from Part I of that Schedule.

S-3 The Misuse of Drugs (Designation) Order 1986 , the Misuse of...

3. The Misuse of Drugs (Designation) Order 19862, the Misuse of Drugs (Designation) (Variation) Order 19903, the Misuse of Drugs (Designation) (Variation) Order 19954and the Misuse of Drugs (Designation) (Variation) Order 19985are revoked.

Bob Ainsworth

Parliamentary Under-Secretary of State

Home Office

13th December 2001

SCHEDULE

SCHEDULE

1 CONTROLLED DRUGS TO WHICH SECTION 7(4) OF THE MISUSE OF DRUGS ACT 1971 APPLIES

PART I

CONTROLLED DRUGS TO WHICH SECTION 7(4) OF THE MISUSE OF DRUGS ACT 1971 APPLIES

SCH-1.1

1. The following substances and products, namely:—

(a) Bufotenine

Mescaline

Cannabinol

Methcathinone

Cannabinol derivatives not being dronabinol or its stereoisomers

Psilocin

Raw opium

Cannabis

Rolicyclidine

Cannabis resin

Tenocyclidine

Cathinone

4-Bromo-2,5-dimethoxy-α-methylphenethylamine

Coca leaf

Concentrate of poppy-straw

N,N-Diethyltryptamine

Eticyclidine

N,N-Dimethyltryptamine

Etryptamine

2,5-Dimethoxy-α,4-dimethyl-phenethylamine

Lysergamide

Lysergide and other N-alkyl derivatives of lysergamide

N-Hydroxy-tenamphetamine

4-Methyl-aminorex;

(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c) the following phenethylamine derivatives, namely—

Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine

2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

2-Amino-1-(3,4-dimethoxyphenyl)ethanol

Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine

4-Bromo-β,2,5-trimethoxyphenethylamine

N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine

2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

2-(1,4-Dimethoxy-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

α,α-Dimethyl-3,4-methylenedioxyphenethylamine

α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine

N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine

2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

β-Methoxy-3,4-methylenedioxyphenethylamine

1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol

α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

α-Methyl-4-(methylthio)phenethylamine

β,3,4,5-Tetramethoxyphenethylamine

β...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT